Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

WCRI Publishes Annual Report

The report summarizes 2024 activities, including over 40 studies that address topics such as psychosocial factors, attorney involvement, and more.
Read More →
April 28, 2025

Nevada Provider Panel Bill Fails

Assembly Bill 469 missed a committee deadline, removing it from consideration this legislative session.
Read More →
April 28, 2025

Nevada Heat Safety Rules to Take Effect April 29th

Employers with over 10 employees working outdoors, or indoors without climate control, must adhere to the new rules.
Read More →
April 28, 2025

Louisiana Fee Schedule Bill Amended with Hopes of Compromise

In addition to bill amendments, the bill has been deferred for one week to allow for additional review and stakeholder input.
Read More →
April 28, 2025

California DWC Launches Test Pilot for New Pharmacy Fee Calculator

The pilot test will run from April 24 to May 8, 2025, allowing stakeholders to provide feedback to the DWC.
Read More →
April 28, 2025

OSHA to Hold Public Hearing on Heat Injury and Illness Prevention

A June 16th virtual hearing will discuss proposed rules, and those interested in speaking must register by May 2nd.
Read More →
April 21, 2025

CMS Publishes Update to NCCI Medically Unlikely Edits

The update includes a revised MUE value for certain HCPCS codes, retroactive to October 1, 2024.
Read More →
April 21, 2025

New York Bill Would Ensure Coverage During Disputes

Employers or insurers would be required to provide immediate medical treatment. If a claim is not compensable, they could seek reimbursement.
Read More →
April 21, 2025

Montana to Allow Physician Assistants and Physical Therapists to Treat Injured Workers

Physician assistants will be able to conduct impairment ratings, while physical therapists are now included in the definition of treating providers.
Read More →
April 21, 2025
1 … 25 26 27 28 29 … 48

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

AMA Updates Impairment Rating Guidelines for the First Time Since 2008

Changes center around improving the assessment of mental and behavioral impairment.
Read More

More Recreational Marijuana Legalization, More Positive Workplace Drug Tests

Connecticut legalizes recreational use, and NCCI expects even more states to follow suit.
Read More

Interstate Variation and Trends in Workers’ Comp Drug Payments

A new flash report from the WCRI highlights trends in drug utilization.
Read More

Mental Health Injuries Gain Momentum in Workers’ Comp

Corrections officers in Nebraska benefit from a new law; will healthcare workers in Connecticut join them?
Read More

FDA Approves Kloxxado for Opioid Overdose

A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.
Read More

FDA Revokes Emergency Use Authorization for Bamlanivimab for COVID-19

Due to mutating viral strains, the potential benefits of this COVID-19 drug no longer outweigh the risks.
Read More
1 … 25 26 27 28 29 … 50
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle